Stocks and Investing
Stocks and Investing
Fri, March 15, 2024
[ Fri, Mar 15th 2024
] - WOPRAI
[ Fri, Mar 15th 2024
] - WOPRAI
[ Fri, Mar 15th 2024
] - WOPRAI
[ Fri, Mar 15th 2024
] - WOPRAI
[ Fri, Mar 15th 2024
] - WOPRAI
[ Fri, Mar 15th 2024
] - WOPRAI
[ Fri, Mar 15th 2024
] - WOPRAI
[ Fri, Mar 15th 2024
] - WOPRAI
[ Fri, Mar 15th 2024
] - WOPRAI
[ Fri, Mar 15th 2024
] - WOPRAI
[ Fri, Mar 15th 2024
] - WOPRAI
[ Fri, Mar 15th 2024
] - WOPRAI
[ Fri, Mar 15th 2024
] - WOPRAI
[ Fri, Mar 15th 2024
] - WOPRAI
[ Fri, Mar 15th 2024
] - WOPRAI
[ Fri, Mar 15th 2024
] - WOPRAI
[ Fri, Mar 15th 2024
] - WOPRAI
[ Fri, Mar 15th 2024
] - WOPRAI
[ Fri, Mar 15th 2024
] - WOPRAI
[ Fri, Mar 15th 2024
] - WOPRAI
[ Fri, Mar 15th 2024
] - WOPRAI
[ Fri, Mar 15th 2024
] - WOPRAI
[ Fri, Mar 15th 2024
] - WOPRAI
[ Fri, Mar 15th 2024
] - WOPRAI
[ Fri, Mar 15th 2024
] - WOPRAI
[ Fri, Mar 15th 2024
] - WOPRAI
[ Fri, Mar 15th 2024
] - WOPRAI
[ Fri, Mar 15th 2024
] - WOPRAI
[ Fri, Mar 15th 2024
] - WOPRAI
[ Fri, Mar 15th 2024
] - WOPRAI
Jason Butler Maintained (AQST) at Buy with Increased Target to $10 on, Mar 15th, 2024
Jason Butler of JMP Securities, Maintained "Aquestive Therapeutics, Inc." (AQST) at Buy with Increased Target from $8 to $10 on, Mar 15th, 2024.
Jason has made no other calls on AQST in the last 4 months.
There are 3 other peers that have a rating on AQST. Out of the 3 peers that are also analyzing AQST, 0 agree with Jason's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Jason
- Raghuram Selvaraju of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $7 on, Monday, March 11th, 2024
- Thomas Flaten of "Lake Street" Maintained at Strong Buy with Increased Target to $8 on, Thursday, March 7th, 2024
- Andreas Argyrides of "Wedbush" Maintained at Buy with Increased Target to $9 on, Thursday, March 7th, 2024
Contributing Sources